GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients

FHS
June 21, 2024
3:08 am

People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from Karolinska Institutet in Sweden published in the journal eClinicalMedicine.

High-sensitivity wastewater surveillance correlates with COVID-19 infections

Wastewater surveillance has gained attention as an effective method for monitoring regional infection trends. In July 2024, the National Action Plan for Novel Influenza, etc.

October 24, 2024

Multidrug-resistant E.coli outcompete harmless strains to take over the gut, study reveals

Different strains of E.coli can outcompete one another to take over the gut, a new study reveals.

October 18, 2023

Pfizer joins Super Bowl ad lineup, toasting Katalin Karikó and other innovators with ‘Here’s to Science’ spot

Pfizer is set to air a 60-second commercial during the Super Bowl on Sunday, marking its first-ever corporate work appearing in the big game. The

February 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.